Electrolyte alterations in vascular smooth muscle and hypotensive activity of a new chalcone derivative.
D000098:Acetophenones / Q000008:administration & dosage / Q000494:pharmacology*; D000804:Angiotensin II / Q000037:antagonists & inhibitors; D000818:Animals; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000494:pharmacology*; D001013:Aorta, Thoracic / Q000032:analysis / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D004285:Dogs; D005260:Female; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects*; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D011188:Potassium / Q000032:analysis / Q000097:blood; D011817:Rabbits; D051381:Rats; D012964:Sodium / Q000032:analysis / Q000097:blood
D000098:Acetophenones; D000959:Antihypertensive Agents; D000804:Angiotensin II; D012964:Sodium; D011188:Potassium; D009638:Norepinephrine